Appointment of Chief Executive Officer
Filed with ASX · · 3 pages · English
Sydney, Australia – 21 January 2021: The Board of OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company) is pleased to announce that Mr Nigel Lange has been appointed as Chief Executive Officer and Managing Director of the Company, effective 21 January 2021. Nigel joined the Company in May 2020 as EMEA President, bringing with him over 30 years of experience in the medical devices industry. Since
Story so far
Earlier from OncoSil Medical
- OncoSil FY21 half yearly review
- Termination of Mr Daniel Kenny as Chief Executive Officer
- OncoSil receives Swiss regulatory approval
- OncoSil achieves first commercial sale
- Positive PanCO trial update on resected cohort
Later from OncoSil Medical
- OncoSil Investor Update
- Appendix 4C - quarterly
- OncoSil receives regulatory approval from Hong Kong
- OncoSil TGA regulatory update
- Receipt of $1.077m R&D Tax Incentive Refund
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical